- Open
- 227.60
- High
- 229.20
- Low
- 225.20
- Close
- 228.80
- Change
- +1.20 (0.53%)
- Volume
- 5,049,380
| 1 Sept 2026 | 11:05:01 | Total Voting Rights |
| 1 Sept 2026 | 11:00:00 | Transaction in Own Shares |
| 27 Aug 2026 | 07:00:04 | Non-Executive Director appointment |
| 24 Aug 2026 | 11:00:00 | Transaction in Own Shares |
| 21 Aug 2026 | 11:00:00 | Percentage of shares held in treasury |
| 10 Mar 2026 | Convatec Group Plc 2025 Annual Report | |
| 10 Mar 2026 | Annual Report and Accounts for the year ending 31 December 2025 | |
| 11 Mar 2025 | Convatec Group Plc 2024 Annual Report and Accounts |
Convatec Group plc develops and manufactures medical products and technologies focused on chronic care. Its primary business segments include Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care, providing solutions for managing wounds, stomas, urinary issues, and infusion therapies. The company serves healthcare professionals and patients globally, with significant operations in North America and Europe, and generates over 90% of its revenue from recurring consumable products.
| 1 Sept 2026 | 11:05:01 | Total Voting Rights |
| 1 Sept 2026 | 11:00:00 | Transaction in Own Shares |
| 27 Aug 2026 | 07:00:04 | Non-Executive Director appointment |
| 24 Aug 2026 | 11:00:00 | Transaction in Own Shares |
| 21 Aug 2026 | 11:00:00 | Percentage of shares held in treasury |
| 10 Mar 2026 | Convatec Group Plc 2025 Annual Report | |
| 10 Mar 2026 | Annual Report and Accounts for the year ending 31 December 2025 | |
| 11 Mar 2025 | Convatec Group Plc 2024 Annual Report and Accounts |
Convatec Group plc develops and manufactures medical products and technologies focused on chronic care. Its primary business segments include Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care, providing solutions for managing wounds, stomas, urinary issues, and infusion therapies. The company serves healthcare professionals and patients globally, with significant operations in North America and Europe, and generates over 90% of its revenue from recurring consumable products.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £9.35bn | -0.2% | |
CTECConvatec Group plc | £4.69bn | -0.0% |
| £3.32bn | -0.1% | |
| £618m | +0.4% | |
| £282m | -0.1% | |
| £63m | -0.2% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £9.35bn | -0.2% | |
CTECConvatec Group plc | £4.69bn | -0.0% |
| £3.32bn | -0.1% | |
| £618m | +0.4% | |
| £282m | -0.1% | |
| £63m | -0.2% |